Sorrento Adds Mesenchymal Stem Cell Program (MSC) That Has Been Cleared for a Phase 1 Trial by the FDA to the Pipeline of COVID-19 Focused Rescue Therapies

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach